Pfizer to pay $59.7 million over kickbacks for migraine drug
1. Pfizer pays $59.7 million to settle Medicare fraud allegations. 2. Charges relate to kickbacks for prescribing migraine drug Nurtec ODT.
FAQ
Why Bearish?
Such legal settlements can lead to negative investor sentiment, as seen with other pharmaceutical companies facing similar issues.
How important is it?
Legal troubles can significantly influence public perception and stock prices of pharmaceuticals like PFE.
Why Short Term?
The immediate financial impact and reputational concerns are likely to affect PFE short-term, similar to prior legal challenges faced by peers.